Hiroki Mitoma

3.8k total citations · 1 hit paper
68 papers, 2.9k citations indexed

About

Hiroki Mitoma is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Hiroki Mitoma has authored 68 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 34 papers in Rheumatology and 10 papers in Molecular Biology. Recurrent topics in Hiroki Mitoma's work include Systemic Lupus Erythematosus Research (25 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (10 papers). Hiroki Mitoma is often cited by papers focused on Systemic Lupus Erythematosus Research (25 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (10 papers). Hiroki Mitoma collaborates with scholars based in Japan, United States and United Kingdom. Hiroki Mitoma's co-authors include Takahiko Horiuchi, Hiroshi Tsukamoto, Shin‐ichi Harashima, T. Shimoda, Naoyasu Ueda, Yasutaka Kimoto, Mine Harada, Yong‐Jun Liu, Koichi Akashi and Hiroaki Niiro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

In The Last Decade

Hiroki Mitoma

63 papers receiving 2.8k citations

Hit Papers

Transmembrane TNF- : structure, function and interaction ... 2010 2026 2015 2020 2010 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Transmembrane TNF- : structure, function and interaction with anti-TNF agents
    2010 648 citations Takahiko Horiuchi, Hiroki Mitoma et al. Lara D. Veeken profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Mitoma Japan 24 1.3k 767 714 375 320 68 2.9k
Michael Bonelli Austria 28 1.7k 1.3× 687 0.9× 976 1.4× 259 0.7× 592 1.9× 72 3.2k
Onelia Bistoni Italy 35 1.5k 1.1× 514 0.7× 778 1.1× 219 0.6× 492 1.5× 96 3.1k
Steven K. Lundy United States 33 1.8k 1.4× 786 1.0× 485 0.7× 323 0.9× 505 1.6× 59 3.5k
Hiroaki Ida Japan 30 1.3k 1.0× 1.0k 1.3× 1.1k 1.5× 413 1.1× 353 1.1× 165 3.3k
Carl S. Goodyear United Kingdom 34 2.1k 1.6× 1.2k 1.6× 767 1.1× 360 1.0× 257 0.8× 110 4.2k
Keishi Fujio Japan 35 2.2k 1.7× 848 1.1× 1.1k 1.5× 418 1.1× 859 2.7× 208 4.1k
Femke van Wijk Netherlands 33 1.5k 1.2× 589 0.8× 403 0.6× 341 0.9× 420 1.3× 113 3.2k
Yi Zhao China 27 1.7k 1.2× 1.0k 1.4× 556 0.8× 240 0.6× 224 0.7× 99 3.1k
Guixiu Shi China 28 857 0.6× 759 1.0× 448 0.6× 275 0.7× 314 1.0× 122 2.4k
Fleur Bossi Italy 29 1.5k 1.1× 600 0.8× 495 0.7× 189 0.5× 226 0.7× 57 2.8k

Countries citing papers authored by Hiroki Mitoma

Since Specialization
Citations

This map shows the geographic impact of Hiroki Mitoma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Mitoma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Mitoma more than expected).

Fields of papers citing papers by Hiroki Mitoma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Mitoma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Mitoma. The network helps show where Hiroki Mitoma may publish in the future.

Co-authorship network of co-authors of Hiroki Mitoma

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Mitoma. A scholar is included among the top collaborators of Hiroki Mitoma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Mitoma. Hiroki Mitoma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamauchi, Yusuke, Yohei Kirino, Yasushi Inoue, et al.. (2024). Cluster analysis defines four groups of Japanese patients with adult-onset Still’s disease. Modern Rheumatology. 34(6). 1213–1220. 3 indexed citations
2.
3.
Kimoto, Yasutaka, Takuya Sawabe, Masahiro Ayano, et al.. (2022). Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study. Modern Rheumatology. 33(2). 367–372. 9 indexed citations
4.
Miyawaki, Kohta, Masahiro Ayano, Yasutaka Kimoto, et al.. (2020). Type 1 helper T cells generate CXCL9/10-producing T-bet+ effector B cells potentially involved in the pathogenesis of rheumatoid arthritis. Cellular Immunology. 360. 104263–104263. 22 indexed citations
5.
Ayano, Masahiro, Yojiro Arinobu, Hiroshi Tsukamoto, et al.. (2020). Shoulder ultrasound and serum lactate dehydrogenase predict inadequate response to glucocorticoid treatment in patients with polymyalgia rheumatica. Rheumatology International. 40(7). 1101–1109. 7 indexed citations
6.
Arinobu, Yojiro, Kohta Miyawaki, Hisakata Yamada, et al.. (2019). CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines. Arthritis Research & Therapy. 21(1). 198–198. 41 indexed citations
7.
Ayano, Masahiro, Hiroshi Tsukamoto, Hiroki Mitoma, et al.. (2019). CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan. Arthritis Research & Therapy. 21(1). 30–30. 26 indexed citations
8.
Kiyohara, Chikako, Takuya Sawabe, Shuji Nagano, et al.. (2018). Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study. PLoS ONE. 13(4). e0196368–e0196368. 44 indexed citations
9.
Arinobu, Yojiro, Koichi Akashi, Koh‐Hei Sonoda, et al.. (2017). Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet’s disease. European Journal of Rheumatology. 5(1). 9–15. 10 indexed citations
10.
Mitoma, Hiroki, Takahiko Horiuchi, Hiroshi Tsukamoto, & Naoyasu Ueda. (2016). Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists. Cytokine. 101. 56–63. 229 indexed citations
11.
Tanaka, Atsushi, Hiroshi Tsukamoto, Hiroki Mitoma, et al.. (2015). Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis. Arthritis Research & Therapy. 17(1). 27–27. 17 indexed citations
12.
Mitoma, Hiroki, Shino Hanabuchi, Tae Il Kim, et al.. (2013). The DHX33 RNA Helicase Senses Cytosolic RNA and Activates the NLRP3 Inflammasome. Immunity. 39(1). 123–135. 172 indexed citations
13.
Ueda, Naoyasu, Hiroshi Tsukamoto, Hiroki Mitoma, et al.. (2013). The Cytotoxic Effects of Certolizumab Pegol and Golimumab Mediated by Transmembrane Tumor Necrosis Factor α. Inflammatory Bowel Diseases. 19(6). 1224–1231. 45 indexed citations
14.
Kiyohara, Chikako, Takahiko Horiuchi, Hiroshi Tsukamoto, et al.. (2012). Prevalence and risk factors of vertebral fracture in female Japanese patients with systemic lupus erythematosus. Modern Rheumatology. 23(4). 765–773. 11 indexed citations
15.
Kimoto, Yasutaka, Takahiko Horiuchi, Hiroshi Tsukamoto, et al.. (2010). Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections. Lara D. Veeken. 49(7). 1346–1353. 20 indexed citations
16.
Ueda, Naoyasu, Yasushi Inoue, Daisuke Himeji, et al.. (2009). Wegener’s granulomatosis detected initially by integrated 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Modern Rheumatology. 20(2). 205–209. 10 indexed citations
17.
Kiyohara, Chikako, Hiroshi Tsukamoto, Hiroki Mitoma, et al.. (2009). Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus. Rheumatology International. 31(3). 365–376. 13 indexed citations
18.
Horiuchi, Takahiko, Chikako Kiyohara, Takuya Sawabe, et al.. (2006). A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case–control study and a meta-analysis. Annals of the Rheumatic Diseases. 66(3). 320–324. 40 indexed citations
19.
Tsukamoto, Hiroshi, Takahiko Horiuchi, Hisashi Kokuba, et al.. (2005). Molecular analysis of a novel hereditary C3 deficiency with systemic lupus erythematosus. Biochemical and Biophysical Research Communications. 330(1). 298–304. 18 indexed citations
20.
Hirata, Kazuho, et al.. (1999). Differential response of macrophage subpopulations to myelin degradation in the injured rat sciatic nerve. Journal of Neurocytology. 28(8). 685–695. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Bonelli Breakdown of academic impact, for papers by Onelia Bistoni Breakdown of academic impact, for papers by Steven K. Lundy Breakdown of academic impact, for papers by Hiroaki Ida Breakdown of academic impact, for papers by Carl S. Goodyear Breakdown of academic impact, for papers by Keishi Fujio Breakdown of academic impact, for papers by Femke van Wijk Breakdown of academic impact, for papers by Yi Zhao Breakdown of academic impact, for papers by Guixiu Shi Breakdown of academic impact, for papers by Fleur Bossi
Rankless by CCL
2026